Taiho Oncology, Inc. | Company Profile, Culture & Jobs

Team and salary summaries are not available for this company yet.

Company overview

The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development and commercialization of orally administered anti-cancer agents for various tumor types. Taiho Oncology has a robust pipeline of small molecule clinical candidates targeting solid tumor and hematological malignancies, with additional candidates in pre-clinical development. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Baar, Switzerland and Oakville, Ontario, Canada. For more information, visit https://www.taihooncology.com.

Founded in 2002

Princeton, New Jersey, USA

436 employees (22 in marketing)

www.taihooncology.com/us

People

Headcount trend

Company growth over the last 12 months

Audience

Monthly website visitors

9.7K

Month over month+50.1%

Quarter over quarter+64.8%

Top sourceDirect (46.3%)

Ad budget per month$0.0

Average search rank36.6

Traffic source mix

Direct

46.3%

Search

29.8%

News

Taiho, Cullinan file rolling NDA on phase I/II zipalertinib data

Nov 21, 2025 • BioWorld MedTech

Taiho Oncology, Taiho Pharmaceutical and Cullinan Therapeutics initiate rolling submission of new drug application to US FDA

Nov 20, 2025 • MarketScreener

Taiho Oncology, Taiho Pharmaceutical and Cullinan Therapeutics Initiate Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Zipalertinib for Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer with EG..

Nov 20, 2025 • Nasdaq

Links

www.taihooncology.com/us

Crunchbase

Taiho Oncology, Inc. insights

Company and marketing-team signals from saved company data and employee profiles. Use this before you apply, interview, or negotiate.

Founded

2002

Headquarters

Princeton, New Jersey

Employees

201-500

Flat last 12mo

Marketing team

22

5% of company

15 saved employee profiles are linked to this company.

Company stability and risk

Shows a quick risk view from growth, funding age, and news.

Main result

Low risk

Seed-stage · Flat headcount last 12 months · More mature

Trend

2022-11-28 -> 2026-02-02

Headcount (12 months)

+4.1%

Last funding round

—

Negative news (120 days)

0

Risk score0/7

Website traffic

Shows traffic size, change, and traffic sources.

Monthly website visitors

9.7K

Month over month+50.1%

Quarter over quarter+64.8%

Top sourceDirect (46.3%)

Traffic source mix

Direct

46.3%

Search

29.8%

Competitors and search

Shows competitors and key search metrics in one view.

Main result

0 competitor sites

Search traffic: 666 organic clicks / 0 paid clicks

Organic competitors

0

Paid competitors

0

Keyword change

-4

Ad budget per month

$0.0

Average search rank

36.6

LinkedIn followers

Shows follower count and growth.

LinkedIn followers

Follower count and growth

Total followers

18.9K

12-mo growth

+37.6%

Monthly growth

+2.8%

Marketing team size

Shows saved marketing team size.

22

5% of the company • 15 saved marketing people

First hire or larger team

Shows if this looks like one hire or a bigger team.

Looks like larger team

Based on saved marketing team size: 22.

News

Shows saved company news.

Taiho, Cullinan file rolling NDA on phase I/II zipalertinib data

Nov 21, 2025 • BioWorld MedTech

Taiho Oncology, Taiho Pharmaceutical and Cullinan Therapeutics initiate rolling submission of new drug application to US FDA

Nov 20, 2025 • MarketScreener

Taiho Oncology, Taiho Pharmaceutical and Cullinan Therapeutics Initiate Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Zipalertinib for Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer with EG..

Nov 20, 2025 • Nasdaq

Loading insights...

Headcount +4.1% year over year

Social

14.7%

Referral

7.4%

Paid referral

1.5%

LinkedIn followers

Follower count and growth

Total followers

18.9K

12-mo growth

+37.6%

Monthly growth

+2.8%

Salaries

Help build salary transparency at Taiho Oncology, Inc.

Share your compensation anonymously to see full data.

Contribute

Open positions2 open marketing positions

Director, Market Access Marketing

Taiho Oncology, Inc.

Princeton, NJ (Hybrid)

$226K/yr - $266K/yrIn-houseFull-timeDirector/executive7+ years exp.

8 days ago

Manager, Medical Communications

Taiho Oncology, Inc.

Princeton, NJ (Hybrid)

$140K/yr - $165K/yrIn-houseFull-time

4 months ago

Taiho Oncology, Inc. insights

Company and marketing-team signals from saved company data and employee profiles. Use this before you apply, interview, or negotiate.

Founded

2002

Headquarters

Princeton, New Jersey

Employees

201-500

Flat last 12mo

Marketing team

22

5% of company

15 saved employee profiles are linked to this company.

Company stability and risk

Shows a quick risk view from growth, funding age, and news.

Main result

Low risk

Seed-stage · Flat headcount last 12 months · More mature

Trend

2022-11-28 -> 2026-02-02

Headcount (12 months)

+4.1%

Last funding round

—

Negative news (120 days)

0

Risk score0/7

Website traffic

Shows traffic size, change, and traffic sources.

Monthly website visitors

9.7K

Month over month+50.1%

Quarter over quarter+64.8%

Top sourceDirect (46.3%)

Traffic source mix

Direct

46.3%

Search

29.8%

Competitors and search

Shows competitors and key search metrics in one view.

Main result

0 competitor sites

Search traffic: 666 organic clicks / 0 paid clicks

Organic competitors

0

Paid competitors

0

Keyword change

-4

Ad budget per month

$0.0

Average search rank

36.6

LinkedIn followers

Shows follower count and growth.

LinkedIn followers

Follower count and growth

Total followers

18.9K

12-mo growth

+37.6%

Monthly growth

+2.8%

Marketing team size

Shows saved marketing team size.

22

5% of the company • 15 saved marketing people

First hire or larger team

Shows if this looks like one hire or a bigger team.

Looks like larger team

Based on saved marketing team size: 22.

News

Shows saved company news.

Taiho, Cullinan file rolling NDA on phase I/II zipalertinib data

Nov 21, 2025 • BioWorld MedTech

Taiho Oncology, Taiho Pharmaceutical and Cullinan Therapeutics initiate rolling submission of new drug application to US FDA

Nov 20, 2025 • MarketScreener

Taiho Oncology, Taiho Pharmaceutical and Cullinan Therapeutics Initiate Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Zipalertinib for Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer with EG..

Nov 20, 2025 • Nasdaq

Social

14.7%

Referral

7.4%

Paid referral

1.5%